nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.0509	0.0665	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.0483	0.0631	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR9—Crohn's disease	0.0421	0.055	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ACKR2—Crohn's disease	0.0388	0.0507	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—MLN—Crohn's disease	0.0368	0.048	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0335	0.0437	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.0311	0.0406	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR6—Crohn's disease	0.0279	0.0364	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCR9—Crohn's disease	0.0255	0.0333	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GPR65—Crohn's disease	0.0237	0.031	CbGpPWpGaD
Bisacodyl—Haematochezia—Mesalazine—Crohn's disease	0.0235	0.1	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.0222	0.029	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—MLN—Crohn's disease	0.0208	0.0271	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ACKR2—Crohn's disease	0.0199	0.026	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0195	0.0255	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MLN—Crohn's disease	0.0189	0.0247	CbGpPWpGaD
Bisacodyl—Anorectal discomfort—Mesalazine—Crohn's disease	0.0173	0.0738	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCR6—Crohn's disease	0.0169	0.0221	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—PTGER4—Crohn's disease	0.0149	0.0194	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR9—Crohn's disease	0.0144	0.0188	CbGpPWpGaD
Bisacodyl—Abdominal cramps—Mesalazine—Crohn's disease	0.014	0.0598	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—GPR65—Crohn's disease	0.0134	0.0175	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR9—Crohn's disease	0.0131	0.0171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GPR65—Crohn's disease	0.0122	0.0159	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ACKR2—Crohn's disease	0.0118	0.0154	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MLN—Crohn's disease	0.0111	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TAGAP—Crohn's disease	0.0102	0.0133	CbGpPWpGaD
Bisacodyl—Colitis—Azathioprine—Crohn's disease	0.00999	0.0425	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR6—Crohn's disease	0.00954	0.0125	CbGpPWpGaD
Bisacodyl—Colitis—Mesalazine—Crohn's disease	0.0091	0.0387	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00898	0.0117	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RSPO3—Crohn's disease	0.00891	0.0116	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR6—Crohn's disease	0.00866	0.0113	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SEL1L—Crohn's disease	0.00844	0.011	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PTGER4—Crohn's disease	0.0084	0.011	CbGpPWpGaD
Bisacodyl—Immune system disorder—Mercaptopurine—Crohn's disease	0.00792	0.0337	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR9—Crohn's disease	0.00772	0.0101	CbGpPWpGaD
Bisacodyl—Malnutrition—Mercaptopurine—Crohn's disease	0.00763	0.0325	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PTGER4—Crohn's disease	0.00762	0.00996	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GPR65—Crohn's disease	0.00718	0.00938	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL3—Crohn's disease	0.00715	0.00935	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00714	0.00933	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00692	0.00904	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL3—Crohn's disease	0.00649	0.00849	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—RASGRP1—Crohn's disease	0.00628	0.00821	CbGpPWpGaD
Bisacodyl—Abdominal discomfort—Azathioprine—Crohn's disease	0.00626	0.0266	CcSEcCtD
Bisacodyl—Cramp muscle—Mesalazine—Crohn's disease	0.0062	0.0264	CcSEcCtD
Bisacodyl—Abdominal discomfort—Mesalazine—Crohn's disease	0.0057	0.0243	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CXCL8—Crohn's disease	0.00544	0.00711	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00538	0.0229	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR6—Crohn's disease	0.00512	0.00669	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL2RA—Crohn's disease	0.00501	0.00655	CbGpPWpGaD
Bisacodyl—Immune system disorder—Azathioprine—Crohn's disease	0.00472	0.0201	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RBX1—Crohn's disease	0.00463	0.00605	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00459	0.0195	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL2RA—Crohn's disease	0.00455	0.00595	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTGER4—Crohn's disease	0.0045	0.00589	CbGpPWpGaD
Bisacodyl—Immune system disorder—Mesalazine—Crohn's disease	0.0043	0.0183	CcSEcCtD
Bisacodyl—Diarrhoea—Mercaptopurine—Crohn's disease	0.00426	0.0182	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—UBE2D1—Crohn's disease	0.00406	0.0053	CbGpPWpGaD
Bisacodyl—Muscle spasms—Mesalazine—Crohn's disease	0.00398	0.017	CcSEcCtD
Bisacodyl—Vomiting—Mercaptopurine—Crohn's disease	0.00396	0.0169	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RIPK2—Crohn's disease	0.00393	0.00514	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL3—Crohn's disease	0.00384	0.00501	CbGpPWpGaD
Bisacodyl—Angioedema—Mesalazine—Crohn's disease	0.00379	0.0161	CcSEcCtD
Bisacodyl—Syncope—Mesalazine—Crohn's disease	0.00372	0.0158	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RASGRP1—Crohn's disease	0.00371	0.00485	CbGpPWpGaD
Bisacodyl—Nausea—Mercaptopurine—Crohn's disease	0.0037	0.0158	CcSEcCtD
Bisacodyl—Loss of consciousness—Mesalazine—Crohn's disease	0.00364	0.0155	CcSEcCtD
Bisacodyl—Anaphylactic shock—Mesalazine—Crohn's disease	0.00338	0.0144	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—JAK2—Crohn's disease	0.00337	0.0044	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS1—Crohn's disease	0.00336	0.00439	CbGpPWpGaD
Bisacodyl—Shock—Mesalazine—Crohn's disease	0.00333	0.0142	CcSEcCtD
Bisacodyl—Nervous system disorder—Mesalazine—Crohn's disease	0.00332	0.0141	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00321	0.0136	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—TYK2—Crohn's disease	0.00321	0.00419	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL8—Crohn's disease	0.00307	0.00402	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—JAK2—Crohn's disease	0.00306	0.004	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00304	0.0129	CcSEcCtD
Bisacodyl—Abdominal pain—Azathioprine—Crohn's disease	0.00293	0.0125	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00292	0.0124	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SMAD3—Crohn's disease	0.0029	0.00379	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL8—Crohn's disease	0.00279	0.00365	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00277	0.0118	CcSEcCtD
Bisacodyl—Hypersensitivity—Azathioprine—Crohn's disease	0.00274	0.0116	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL2RA—Crohn's disease	0.00269	0.00351	CbGpPWpGaD
Bisacodyl—Abdominal pain—Mesalazine—Crohn's disease	0.00267	0.0114	CcSEcCtD
Bisacodyl—Diarrhoea—Azathioprine—Crohn's disease	0.00254	0.0108	CcSEcCtD
Bisacodyl—Hypersensitivity—Mesalazine—Crohn's disease	0.00249	0.0106	CcSEcCtD
Bisacodyl—Dizziness—Azathioprine—Crohn's disease	0.00246	0.0105	CcSEcCtD
Bisacodyl—Vomiting—Azathioprine—Crohn's disease	0.00236	0.0101	CcSEcCtD
Bisacodyl—Headache—Azathioprine—Crohn's disease	0.00233	0.0099	CcSEcCtD
Bisacodyl—Diarrhoea—Mesalazine—Crohn's disease	0.00231	0.00985	CcSEcCtD
Bisacodyl—Immune system disorder—Prednisone—Crohn's disease	0.00227	0.00969	CcSEcCtD
Bisacodyl—Dizziness—Mesalazine—Crohn's disease	0.00224	0.00952	CcSEcCtD
Bisacodyl—Nausea—Azathioprine—Crohn's disease	0.00221	0.00939	CcSEcCtD
Bisacodyl—Malnutrition—Prednisone—Crohn's disease	0.00219	0.00933	CcSEcCtD
Bisacodyl—Vomiting—Mesalazine—Crohn's disease	0.00215	0.00915	CcSEcCtD
Bisacodyl—Headache—Mesalazine—Crohn's disease	0.00212	0.00902	CcSEcCtD
Bisacodyl—Nausea—Mesalazine—Crohn's disease	0.00201	0.00855	CcSEcCtD
Bisacodyl—Angioedema—Prednisone—Crohn's disease	0.002	0.00853	CcSEcCtD
Bisacodyl—Syncope—Prednisone—Crohn's disease	0.00197	0.00837	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisone—Crohn's disease	0.00193	0.0082	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—TYK2—Crohn's disease	0.00189	0.00247	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JAK2—Crohn's disease	0.00181	0.00236	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Prednisone—Crohn's disease	0.00179	0.00762	CcSEcCtD
Bisacodyl—Shock—Prednisone—Crohn's disease	0.00176	0.00749	CcSEcCtD
Bisacodyl—Nervous system disorder—Prednisone—Crohn's disease	0.00175	0.00747	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CXCL8—Crohn's disease	0.00165	0.00215	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—Crohn's disease	0.00157	0.00205	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Prednisone—Crohn's disease	0.00146	0.00623	CcSEcCtD
Bisacodyl—Abdominal pain—Prednisone—Crohn's disease	0.00141	0.00602	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—STAT3—Crohn's disease	0.00133	0.00173	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Prednisone—Crohn's disease	0.00132	0.00561	CcSEcCtD
Bisacodyl—Diarrhoea—Prednisone—Crohn's disease	0.00122	0.00521	CcSEcCtD
Bisacodyl—Dizziness—Prednisone—Crohn's disease	0.00118	0.00504	CcSEcCtD
Bisacodyl—Vomiting—Prednisone—Crohn's disease	0.00114	0.00484	CcSEcCtD
Bisacodyl—Headache—Prednisone—Crohn's disease	0.00112	0.00477	CcSEcCtD
Bisacodyl—Nausea—Prednisone—Crohn's disease	0.00106	0.00452	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL6—Crohn's disease	0.000926	0.00121	CbGpPWpGaD
